Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 18, 2018
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
Wed, October 17, 2018
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
[ Wed, Oct 17th 2018
] - WOPRAI
Patrick Donnelly Initiated (BIO) at Strong Buy and Held Target at $350 on, Oct 17th, 2018
Patrick Donnelly of Goldman Sachs, Initiated "Bio-Rad Laboratories, Inc." (BIO) at Strong Buy and Held Target at $350 on, Oct 17th, 2018.
Patrick has made no other calls on BIO in the last 4 months.
There are 3 other peers that have a rating on BIO. Out of the 3 peers that are also analyzing BIO, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Steve Beuchaw of "Morgan Stanley" Initiated at Hold and Held Target at $335 on, Thursday, September 20th, 2018
- Jack Meehan of "Barclays" Initiated at Hold and Held Target at $345 on, Wednesday, September 5th, 2018
This is the rating of the analyst that currently disagrees with Patrick
- Brandon Couillard of "Jefferies" Maintained at Strong Buy with Increased Target to $355 on, Wednesday, August 8th, 2018
